Clinical Trials Directory

Trials / Unknown

UnknownNCT02027831

NIR Fluorescence Imaging During Neck Dissection in Head and Neck Cancer Patients After iv Injection of ICG

Near-infrared Fluorescence Imaging During Neck Dissection in Head and Neck Cancer Patients After Intravenous Injection of Indocyanine Green (a Feasibility Study)

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
Jules Bordet Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine if NIR fluorescent imaging is an effective approach to detect the margins of head and neck tumours or lymph nodes draining the tumour

Detailed description

Primary objective: definition of the distribution of intravenously injected ICG in the normal and pathological lymph nodes draining the dissected tumor in head and neck cancer patients or in nodes recurrences in head and neck cancer Secondary objectives: * Evaluation of the ability of NIR fluorescence imaging to determine the tumoral volume, specifically the margins of the tumoral tissues (in the operating room and in the pathology department) * Analysis of the correlation between ICG fluorescence and tumoral invasion in the dissected lymph nodes

Conditions

Interventions

TypeNameDescription
DRUGIndocyanine Green

Timeline

Start date
2013-12-01
Primary completion
2014-10-01
Completion
2014-10-01
First posted
2014-01-06
Last updated
2014-07-24

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT02027831. Inclusion in this directory is not an endorsement.